Author:
Rosenberg Steven A.,Yang James C.,Schwartzentruber Douglas J.,Hwu Patrick,Marincola Francesco M.,Topalian Suzanne L.,Restifo Nicholas P.,Dudley Mark E.,Schwarz Susan L.,Spiess Paul J.,Parkhurst Maria R.,Kawakami Yutaka,Seipp Claudia A.,Einhorn Jan H.,White Donald E.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference38 articles.
1. Rosenberg, S.A. The development of new cancer therapies based on the molecular identification of cancer regression antigens. Cancer. Sci. Am. 1, 89–100 (1995).
2. Boon, T. Tumor antigens recognized by cytolytic T lymphocytes: Present perspectives for specific immunotherapy. Int. J. Cancer 54, 177–180 (1993).
3. Rosenberg, S.A. et al. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: Preliminary report. N. Engl. J. Med. 319, 1676–1680 (1988).
4. Rosenberg, S.A. et al. Treatment of patients with metastatic melanoma using autologous tumor-infiltrating lymphocytes and interleukin-2. J. Natl. Cancer Inst 86, 1159–1166(1994).
5. Kawakami, Y. et al. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91, 6458–6462 (1994).
Cited by
1557 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献